ALN-F1202

· Regeneron Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALN-F1202, covering 2026-02-23 to 2026-02-23. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Safety and Tolerability Study of ALN-F1202 in Healthy Adults [Phase 1]